EcoDrugPlus

Cyclin Dependent Kinase 6

Ensembl ID : ENSOMEG00000016622
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSOMEG00000004854
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSOMEG00000004738
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSOMEG00000014852
Gene Symbol: CYSLTR1
3 Cross references
172 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSOMEG00000019061
Gene Symbol: CDA
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSOMEG00000014802
Gene Symbol: LOC112162325
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a40

Ensembl ID : ENSOMEG00000021770
Gene Symbol: LOC112137330
3 Cross references
540 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSOMEG00000012892
Gene Symbol: LOC112161723
2 Cross references
522 Possible Orthologues:

Cytochrome P450 3a56-Like

Ensembl ID : ENSOMEG00000012937
Gene Symbol: LOC112161724
2 Cross references
522 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSOMEG00000016270
Gene Symbol: CYP19A1
2 Cross references
244 Possible Orthologues:

Cytochrome P450, Family 17, Subfamily A, Polypeptide 1

Ensembl ID : ENSOMEG00000002201
Gene Symbol: CYP17A1
1 Cross references
210 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily A, Polypeptide 65

Ensembl ID : ENSOMEG00000021856
Gene Symbol: CYP3A65
1 Cross references
540 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).